Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Sep 7, 2009; 15(33): 4163-4169
Published online Sep 7, 2009. doi: 10.3748/wjg.15.4163
Published online Sep 7, 2009. doi: 10.3748/wjg.15.4163
Table 2 Stimulation index at different concentrations of fentanyl and naloxone (mean ± SD, n = 12)
| Fentanyl | Fentanyl + 0.1μg/mL naloxone | Fentanyl + 1μg/mL naloxone | |
| Control (0 ng/mL) | 2.01 ± 0.21 | 2.02 ± 0.21 | 2.02 ± 0.21 |
| I (0.3 ng/mL) | 2.17 ± 0.36 | 2.07 ± 0.35 | 2.08 ± 0.26 |
| II (3 ng/mL) | 2.04 ± 0.26 | 1.95 ± 0.23 | 1.99 ± 0.34 |
| III (30 ng/mL) | 1.89 ± 0.16 | 1.89 ± 0.19 | 2.08 ± 0.27 |
| Naloxone | 1.97 ± 0.29 | 2.04 ± 0.28 |
- Citation: Qian TL, Wang XH, Liu S, Ma L, Lu Y. Fentanyl inhibits glucose-stimulated insulin release from β-cells in rat pancreatic islets. World J Gastroenterol 2009; 15(33): 4163-4169
- URL: https://www.wjgnet.com/1007-9327/full/v15/i33/4163.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4163